Crossmark

β-caryophyllene cationic nanoemulsion for intranasal delivery and treatment of epilepsy: development and in vivo evaluation of anticonvulsant activity

Crossref DOI link: https://doi.org/10.1007/s11051-023-05668-8

Published Online: 2023-01-10

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nogueira, Camila

Lemos-Senna, Elenara

da Silva Vieira, Edna

Sampaio, Tuane Bazanella

Mallmann, Michele Pereira

Oliveira, Mauro Schneider

Bernardi, Larissa Sakis

Oliveira, Paulo Renato https://orcid.org/0000-0003-0466-1327
Funding

Funding for this research was provided by:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
License Information

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-01-01
More Information

Article History

Received: 1 June 2022

Accepted: 3 January 2023

First Online: 10 January 2023

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below